Thymosin alpha-1 (5mg)

King and Tuthill describe thymosin alpha-1 as a peptide with effects across more than one immune-cell subset, not a single-receptor ligand with one tidy readout.^[1] In their review, the peptide acts through Toll-like receptors on myeloid and plasmacytoid dendritic cells, which then turn on signaling pathways and immune-related cytokine production.^[1]

That is why labs keep it on an immuno-assay bench. A dendritic-cell maturation plate, a T-cell subset panel, or a cytokine multiplex can all sit on the same lot if the identity work is done first. The literature they summarize is a mix of preclinical models and clinical-program write-ups of branded thymalfasin. Those write-ups do not travel with a research vial.

Searches for thymosin alpha 1 peptide fda approved are usually looking for Zadaxin, the branded thymalfasin product that some countries have licensed as an immune biologic.^[1] That license, where it exists, belongs to a finished drug with its own manufacturer, label, and supply chain.

Tetrava's listing is a Research Use Only powder. It is not Zadaxin. It is not thymalfasin as a dispensed medicine. An approval story about a branded immune biologic does not make a catalog vial an approved drug in the United States or anywhere else.

The review walks through immune-modulation data for thymosin alpha-1 after the original thymic isolation work.^[1] The mechanism they put in the foreground is dendritic-cell TLR engagement, then downstream cytokine output and changes in immune-cell subsets used in infection and cancer immunology papers.

They treat that body of work as a rationale for studying immune suppression in the lab and in branded-product programs. They do not convert it into a protocol for a research-chemical vial. If a method section in your lab needs a concentration or exposure time, pull it from the primary paper for that assay. Do not borrow a clinical-program schedule.

The useful comparison is supply chain, not sequence trivia. Zadaxin is a licensed finished product in some markets. This page is a documented RUO reagent in the shop, sold for plate work and animal-model immunology, not as a substitute biologic.

If a protocol needs a thymic-peptide arm next to other immune-modulating reagents, keep the lot identity on the plate map. Do not treat a branded-drug paper as a certificate for the powder you received. Thymosin alpha-1 is not interchangeable with TB-500. They are different thymic fragments.

A thymosin alpha-1 peptide buy online is a documentation question before it is a price question. Thymosin alpha 1 price searches often want a pharmacy number. This page shows a research SKU, including 5 mg and 10 mg vials, not a formulary product.

Lot on the vial should match the lot on the Certificate of Analysis. A percent line with no lot-linked HPLC or MS record is catalog copy. The listing should describe a laboratory reagent, not a substitute for Zadaxin.

Thymosin alpha-1 ships lyophilized. Store sealed vials at -20 C. Log diluent lot, concentration, date, and operator so the prep still matches the batch COA.